Taha Toros Arşivi, Dosya No: 22-Haluk Yusuf Şehsuvaroğlu. Not: Gazetenin "Tarihi Bahisler" köşesinde yayımlanmıştır.İstanbul Kalkınma Ajansı (TR10/14/YEN/0033) İstanbul Development Agency (TR10/14/YEN ...
Şehsuvaroğlu, Haluk Yusuf
core
Integrating Biochemical and Computational Approaches Reveal Structural Insights in Trastuzumab scFv-Fc Antibody Engineering. [PDF]
BiomoleculesBednova O +9 more
europepmc +1 more source
Severing Ties: Quantifying the Payload Release from Antibody Drug Conjugates. [PDF]
Cell Chem Biol, 2019 Kopp A, Thurber GM.
europepmc +1 more source
Disitamab vedotin in preclinical models of HER2-positive breast and gastric cancers resistant to trastuzumab emtansine and trastuzumab deruxtecan. [PDF]
Transl OncolPourjamal N +8 more
europepmc +1 more source
Therapeutic efficacy of the humanized JAA-F11 anti-Thomsen-Friedenreich antibody constructs H2aL2a and H3L3 in human breast and lung cancer xenograft models. [PDF]
Oncotarget, 2022 Ghazal D +9 more
europepmc +1 more source
Promenade doorheen de schemerzone. Een wandelroute langs symfonieën en concerto's van Mozart, Monn, Bach en Beck [PDF]
, 2003 Forment, Bruno
core
Sex hormone supplementation improves breathing and restores respiratory neuroplasticity following C2 hemisection in rats. [PDF]
Front PhysiolBarok R +3 more
europepmc +1 more source
Verwikkeld in een soort van serpentine: deleuzes concept van het maniërisme tussen Bacon en de barok [PDF]
, 2009 van Tuinen, Sjoerd
core
Comparison of trastuzumab emtansine, trastuzumab deruxtecan, and disitamab vedotin in a multiresistant HER2-positive breast cancer lung metastasis model. [PDF]
Clin Exp MetastasisPourjamal N +7 more
europepmc +1 more source
From AVATAR Mice to Patients: RC48-ADC Exerted Promising Efficacy in Advanced Gastric Cancer With HER2 Expression. [PDF]
Front Pharmacol, 2021 Chen Z +8 more
europepmc +1 more source